The NIH announced the beginning of a phase 1 first-in-human trial of a vaccine for Lassa fever, a potentially fatal viral hemorrhagic disease for which there is no approved vaccine or treatment.

As President Donald Trump’s administration moves to restrict federal funding for “gender ideology,” new scrutiny is falling ...

Although grants on mRNA-vaccine research have not yet been terminated en masse as they have for other topics — including ...

An experimental treatment appears to postpone Alzheimer's symptoms in some people genetically destined to get the disease at ...

We live in a world where powerful universities cower like congressmen, afraid to complain lest they lose the clout they are ...

UAMS joins the NIH's CARE for Health initiative to enhance rural health research. Partnering with UAB and the University of ...

About the National Institute of Neurological Disorders and Stroke (NINDS): NINDS is the nation’s leading funder of research ...

Existing research indicates that the accuracy of a Parkinson’s disease diagnosis hovers between 55% and 78% in the first five years of assessment. That’s partly because Parkinson’s sibling movement ...

Overnight, leading research institutions in the USA have potentially lost billions of dollars in indirect funding, in a move that will likely change the biomedical research landsc ...

NIH-funded study supports the use of adenotonsillectomy in this at-risk patient group.

Tecovirimat failed to reduce clade II mpox lesions, pain or viral clearance among participants in a study of the antiviral ...